Company History

HCV-TARGET

Formed in 2015, TARGET PharmaSolutions was created as an outcome of the success of HCV-TARGET, a case study of the TARGET Model for hepatitis C. HCV-TARGET was a partnership with academia, the FDA and industry established in 2011 by Michael W. Fried, MD, FAASLD and David R. Nelson, MD, which has enrolled 14,000+ patients across 60 sites in North America and Europe.

The evidence from HCV-TARGET has been utilized by regulators to monitor post-marketing drug safety, and by sponsors to support label expansion and mitigate phase IV commitments. In late 2018, Dr. Fried and members of the HCV-TARGET team received a Civilian Honor Award for Regulatory Science Excellence “For outstanding public-private partnership leveraging real-world evidence.” 

The HCV-TARGET case study has helped inform national and international treatment guidelines, been used in payer dossiers, and has resulted in numerous high impact scientific presentations and publications. To date, there have been a total of 9 manuscript publications and 28 abstract presentations generated from the study. Importantly, this proven model from HCV-TARGET shaped the foundation of our TARGET PharmaSolutions company.

at a glance:

  • Located in Durham, NC
  • 10 Leading Pharmaceutical Company Partnerships 
  • 250+ Community & Academic Sites
  • 7 Disease Communities 
  • 40+ Publications with more than 70 Unique Authors
  • Key Opinion Leaders on Academic & Publication Steering Committees

Company Timeline

2011

stacked books

HCV-TARGET Study

February 2015

stacked books

TARGET PharmaSolutions founded

July 2016

stacked books

Launched NASH community

October 2016

stacked books

Launched PBC community

January 2017

stacked books

Launched HCC community

July 2017

stacked books

Launched IBD community

November 2017

stacked books

Executed CRADA with FDA

January 2018

stacked books

Site expansion in Europe

August 2018

stacked books

Launched HBV community

January 2019

stacked books

Launched DERM community

January 2020

stacked books

New CEO Announced

March 2020

stacked books

Launched ASTHMA community